[Federal Register Volume 69, Number 107 (Thursday, June 3, 2004)]
[Notices]
[Pages 31388-31391]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-12569]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


HIV Prevention With National Medical and Nursing Associations

    Announcement Type: New.
    Funding Opportunity Number: 04152.
    Catalog of Federal Domestic Assistance Number: 93.118.
    Key Dates: Letter of Intent Deadline: June 18, 2004.
    Application Deadline: July 19, 2004.
    Executive Summary: The Centers for Disease Control and Prevention 
(CDC) announces the availability of fiscal year (FY) 2004 funds for a 
cooperative agreement program with national medical and nursing 
associations or societies to promote and assist with the implementation 
of CDC's Initiative Advancing HIV Prevention: New Strategies for a 
Changing Epidemic. The initiative aims to reduce barriers to early 
diagnosis of HIV infection and increase access to quality medical care, 
treatment, and ongoing prevention services. It emphasizes the use of 
proven public health approaches to reducing the incidence and spread of 
disease. As with other sexually transmitted diseases (STDs) or any 
other public health problem, principles commonly applied to prevent 
disease and its spread will be used, including appropriate routine 
screening, identification of new cases, partner notification, and 
increased availability of sustained treatment and prevention services 
for those infected.
    The initiative consists of four key strategies:
     Make HIV testing a routine part of medical care.
     Implement new models for diagnosing HIV infections outside 
medical settings.
     Prevent new infections by working with persons diagnosed 
with HIV and their partners.
     Further decrease perinatal HIV transmission.

I. Funding Opportunity Description

    Authority: This program is authorized under sections 301(a) and 
317(k)(2) of the Public Health Service Act, (42 U.S.C. 241(a) and 
274b(k)(2)), as amended.

    Purpose: The purpose of this program is to: (1) Develop and 
disseminate provider educational and training materials to members; (2) 
promote HIV testing as part of routine medical care; (3) promote the 
incorporation of HIV prevention into the medical care of HIV-infected 
persons; (4) foster the exchange of information, ideas and experiences 
of health care providers on what works for preventing HIV; and (5) 
stimulate involvement and participation of regional, state and local 
chapters. This program addresses the ``Healthy People 2010'' focus area 
of HIV.
    Measurable outcomes of the program will be in alignment with one or 
more of the following performance goals for the National Center for 
HIV, STD and TB Prevention (NCHSTP): (1) Decrease the number of persons 
at high risk for acquiring or transmitting HIV infection; (2) increase 
the proportion of HIV-infected persons who know they are infected; (3) 
increase the proportion of HIV-infected persons who are linked to 
appropriate prevention, care, and treatment services; (4) strengthen 
the capacity nationwide to monitor the epidemic, develop and implement 
effective HIV prevention interventions and evaluate prevention 
programs.
    Activities: Awardee activities for this program are as follows:
    a. Evaluate members for (1) knowledge, attitudes and perceptions 
regarding the role of clinicians in HIV prevention; (2) adherence to 
practice standards and federal or state clinical guidelines for the 
prevention and treatment of HIV/AIDS and other STDs; (3) knowledge, 
attitudes and barriers to the incorporation of the CDC/HRSA/NIH/IDSA 
Recommendations to Incorporate HIV Prevention into the Medical Care of 
Persons Living with HIV, into their clinical practice.
    b. Assess capacity of regional, State and local chapters to support 
the dissemination of educational and training materials.
    c. Develop and disseminate provider training and educational 
materials to promote HIV testing as part of routine medical care; 
promote the incorporation of HIV prevention into the medical care of 
persons living with HIV; and develop educational materials that 
providers can use with their patients. Dissemination can be done 
directly to members or through regional, State and local chapters.
    d. Sponsor a variety of forums for presentation of information on 
HIV testing as part of routine medical care; use of rapid testing in 
medical settings, including acute care clinics and emergency 
departments; and incorporation of HIV prevention into the medical care 
of HIV-infected persons.
    e. Conduct an evaluation of the intervention to measure changes in 
attitudes, clinical behaviors and practices.
    f. Collaborate with other funded national organizations and the 
Division of HIV/AIDS Prevention, CDC, in the

[[Page 31389]]

development of training and educational materials for health care 
providers and consumers.
    g. Participate in two grantee meetings per year as defined by the 
project officer.
    In a cooperative agreement, CDC staff is substantially involved in 
the program activities, above and beyond routine grant monitoring.
    CDC Activities for this program are as follows:
    a. Facilitate and assist in the development of training materials 
and curricula, administrative tools and policy manuals.
    b. Participate in the evaluation design.
    c. Provide information and technical expertise in the area of HIV 
prevention, including prevention for persons living with HIV.
    d. Work with each awardee to facilitate and support collaboration 
among funded national organizations as well as CDC-funded HIV 
prevention and surveillance programs.
    e. Provide a synthesis of known best practices and interventions 
regarding HIV risk assessment and testing, HIV prevention in medical 
settings, rapid HIV testing, and prevention for HIV-infected persons.
    f. Collaborate in the development of forums that focus on HIV 
testing as part of routine medical care; use of rapid testing in 
medical settings, including acute care clinics and emergency 
departments; and incorporating HIV prevention into the medical care of 
HIV-infected persons.
    g. Collaborate with awardees on presentations and publications of 
evaluation findings.
    h. Conduct site visits to monitor progress of the programs.

II. Award Information

    Type of Award: Cooperative agreement.
    CDC involvement in this program is listed in the Activities Section 
above.
    Fiscal Year Funds: 2004.
    Approximate Total Funding: $500,000.
    Approximate Number of Awards: Three-Four.
    Approximate Average Award: $100,000. (This amount is for the first 
12-month budget period, and includes both direct and indirect costs.)
    Floor of Award Range: $75,000.
    Ceiling of Award Range: $175,000.
    Anticipated Award Date: September 1, 2004.
    Budget Period Length: 12 months.
    Project Period Length: Two years.
    Throughout the project period, CDC's commitment to continuation of 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the recipient (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the Federal government.

III. Eligibility Information

III.1. Eligible applicants

     Applications may be submitted by public and private 
nonprofit organizations.
    This program is limited to national professional medical and 
nursing associations or societies that have the capability to reach a 
broad constituency to assure the dissemination of consistent HIV 
prevention messages nationwide. These associations or societies must 
represent practicing clinicians.
    Funding preference will be given to national organizations with 
prior experience in developing and disseminating provider educational 
and training materials to promote prevention services.

III.2. Cost Sharing or Matching

    Matching funds are not required for this program.

III.3. Other

    If you request a funding amount greater than the ceiling of the 
award range, your application will be reviewed and, if awarded, only 
partially funded.

    Note: Title 2 of the United States Code, section 1611, states 
that an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant, or loan.

IV. Application and Submission Information

IV.1. Address To Request Application Package

    To apply for this funding opportunity use application form PHS 
5161. Application forms and instructions are available on the CDC Web 
site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to 
you.

IV.2. Content and Form of Submission

    Letter of Intent (LOI): Your LOI must be written in the following 
format:
     Maximum number of pages: one.
     Font size: 12-point unreduced.
     Single spaced.
     Paper size: 8.5 by 11 inches.
     Page margin size: One inch.
     Printed only on one side of page.
     Written in plain language, avoid jargon.
    Your LOI must contain the following information:
     A summary of the project.
    Application: You must submit a project narrative with your 
application forms. The narrative must be submitted in the following 
format:
     Maximum number of pages: 20.
    If your narrative exceeds the page limit, only the first pages, 
which are within the page limit, will be reviewed.
     Font size: 12 point unreduced.
     Paper size: 8.5 by 11 inches.
     Page margin size: One inch.
     Printed only on one side of page.
     Held together only by rubber bands or metal clips; not 
bound in any other way.
    Your narrative should address activities to be conducted over the 
entire project period, and must include the following items in the 
order listed:
    1. Abstract (not to exceed one page): An executive summary of your 
program covered under this announcement.
    2. Program Plan (Not to exceed 19 pages): In developing the 
application under this announcement, please review the recipient 
activities and, in particular, evaluation criteria and respond 
concisely and completely. The program plan should address activities to 
be conducted over the entire two-year budget period. Include proposed 
methods and staffing plan for the project.
    3. Budget: Submit an itemized budget for the entire two-year 
project period, and supporting justification that is consistent with 
your proposed program plan. Include travel costs for not more than two 
staff members to attend two 2-day meetings in Atlanta each year.
    Additional information may be included in the application 
appendices. The appendices will not be counted toward the narrative 
page limit. This additional information can include:
     Organizational chart, resumes for proposed staff, a letter 
of support from the board of directors, and letters of support from 
other project partners or collaborators;
     Samples of previous projects related to this proposal.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. The DUNS number is a nine-digit 
identification number, which uniquely identifies business entities. 
Obtaining a DUNS number is easy and there is no charge. To obtain

[[Page 31390]]

a DUNS number, access http://www.dunandbradstreet.com or call 1-866-
705-5711.
    For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm. If your application form does not have a 
DUNS number field, please write your DUNS number at the top of the 
first page of your application, and/or include your DUNS number in your 
application cover letter. Additional requirements that may require you 
to submit additional documentation with your application are listed in 
section ``VI.2. Administrative and National Policy Requirements.''

IV.3. Submission Dates and Times

    LOI Deadline Date: June 18, 2004.
    CDC requests that you send a LOI if you intend to apply for this 
program. Although the LOI is not required, not binding, and does not 
enter into the review of your subsequent application, the LOI will be 
used to gauge the level of interest in this program, and to allow CDC 
to plan the application review.
    Application Deadline Date: July 19, 2004.
    Explanation of Deadlines: Applications must be received in the CDC 
Procurement and Grants Office by 4 p.m. eastern time on the deadline 
date. If you send your application by the United States Postal Service 
or commercial delivery service, you must ensure that the carrier will 
be able to guarantee delivery of the application by the closing date 
and time. If CDC receives your application after closing due to: (1) 
Carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, you will be given the opportunity to 
submit documentation of the carriers guarantee. If the documentation 
verifies a carrier problem, CDC will consider the application as having 
been received by the deadline.
    This announcement is the definitive guide on application submission 
address and deadline. It supersedes information provided in the 
application instructions. If your application does not meet the 
deadline above, it will not be eligible for review, and will be 
discarded. You will be notified that your application did not meet the 
submission requirements.
    CDC will not notify you upon receipt of your application. If you 
have a question about the receipt of your application, first contact 
your courier. If you still have a question, contact the PGO-TIM staff 
at: 770-488-2700. Before calling, please wait two to three days after 
the application deadline. This will allow time for applications to be 
processed and logged.

IV.4. Intergovernmental Review of Applications

    Executive Order 12372 does not apply to this program.

IV.5. Funding Restrictions

    Restrictions, which must be taken into account while writing your 
budget, are as follows:
     Funds from this cooperative agreement should not be used 
for major purchase of equipment or construction. Requests for equipment 
such as computers and Liquid Crystal Display (LCD) Projectors for 
training require detailed justification.
    If you are requesting indirect costs in your budget, you must 
include a copy of your indirect cost rate agreement. If your indirect 
cost rate is a provisional rate, the agreement should be less than 12 
months of age.
    Awards will not allow reimbursement of pre-award costs.
    Guidance for completing your budget can be found on the CDC Web 
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm.

IV.6. Other Submission Requirements

    LOI Submission Address: Submit your LOI by express mail, delivery 
service, fax, or e-mail to: Raul A. Romaguera, DMD, MPH, Associate 
Director for Prevention in Care, Division of HIV/AIDS Prevention, CDC, 
1600 Clifton Road, NE.--MS D-21, Atlanta, GA 30333. Telephone: (404) 
639-2004, fax (404) 639-0897, e-mail: [email protected].
    Application Submission Address: Submit the original and two hard 
copies of your application by mail or express delivery service to: 
Technical Information Management-PA 04152, CDC Procurement and 
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341.
    Applications may not be submitted electronically at this time.

V. Application Review Information

V.1. Criteria

    You are required to provide measures of effectiveness that will 
demonstrate the accomplishment of the various identified objectives of 
the cooperative agreement. Measures of effectiveness must relate to the 
performance goals stated in the ``Purpose'' section of this 
announcement. Measures must be objective and quantitative, and must 
measure the intended outcome. These measures of effectiveness must be 
submitted with the application and will be an element of evaluation. 
Your application will be evaluated against the following criteria:
    1. Scope of Plan (30 points): The plan delineates your steps to 
implement and evaluate your program. It must be written for your entire 
two-year project period and include a succinct statement of the intent, 
desired outcome(s) of the project and clearly stated and measurable 
outcome objectives to be achieved by the project. These objectives must 
be quantifiable in terms of outputs and time frame for achievement. The 
statement of intent and outcome objectives should address the purpose 
of the cooperative agreement, which is to: (1) Develop and disseminate 
provider educational and training materials to members; (2) promote HIV 
testing as part of routine medical care; (3) promote the incorporation 
of HIV prevention into the medical care of HIV-infected persons; (4) 
foster the exchange of information, ideas and experiences of health 
care providers on what works for preventing HIV; (5) stimulate 
involvement and participation of regional, state and local chapters.
    2. Methods (30 points): Clear statement of approach and activities 
required to achieve the stated HIV prevention outcome objectives. The 
relationship between activities and objectives must be explicitly 
demonstrated. Description of activities must include a delineation of 
resources required, identification of the personnel who will perform 
the work and a management plan with description of the systems and 
procedures which will be used to manage the progress, budget and 
operations of the project.
    3. Personnel and Staffing (25 points): The qualifications and 
experience of key personnel, other professional staff and support staff 
available to carry out HIV prevention activities.
    4. Evaluation (15 points): Detailed plans for evaluating the degree 
to which the program achieves the purpose of the cooperative agreement 
(as listed in the purpose section, and above in the description of the 
scope of plan). Measures must be objective and quantitative and must 
measure the intended outcome.
    5. Budget (reviewed, but not scored): There is an upper limit of 
$175,000. An application submitted with a budget over $175,000, will be 
reviewed and, if awarded, only partially funded. The budget will be 
reviewed to determine the extent to which it is reasonable, clearly 
justified, consistent with the intended use of the funds, and

[[Page 31391]]

allowable. All budget categories should be itemized.

V.2. Review and Selection Process

    Applications will be reviewed for completeness by the Procurement 
and Grants Office (PGO) staff and for responsiveness by the NCHSTP. 
Incomplete applications and applications that are non-responsive to the 
eligibility criteria will not advance through the review process. 
Applicants will be notified that their application did not meet 
submission requirements.
    An objective review panel will evaluate complete and responsive 
applications according to the criteria listed in the ``V.1. Criteria'' 
section above.
    In addition, the following factors may affect the funding decision:
    This program is limited to national professional medical and 
nursing associations or societies that have the capability to reach a 
broad constituency to assure the dissemination of consistent HIV 
prevention messages nationwide. These associations or societies must 
represent practicing clinicians.
    Funding preference will be given to national organizations with 
prior experience in developing and disseminating provider educational 
and training materials to promote prevention services.

V.3. Anticipated Announcement and Award Dates

    September 1, 2004.

VI. Award Administration Information

VI.1. Award Notices

    Successful applicants will receive a Notice of Grant Award (NGA) 
from the CDC Procurement and Grants Office. The NGA shall be the only 
binding, authorizing document between the recipient and CDC. The NGA 
will be signed by an authorized Grants Management Officer, and mailed 
to the recipient fiscal officer identified in the application.
    Unsuccessful applicants will receive notification of the results of 
the application review by mail.

VI.2. Administrative and National Policy Requirements

45 CFR part 74 and part 92
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    The following additional requirements apply to this project:
     AR-4 HIV/AIDS Confidentiality Provisions.
     AR-5 HIV Program Review Panel Requirements.
     AR-9 Paperwork Reduction Act Requirements.
     AR-10 Smoke-Free Workplace Requirements.
     AR-11 Healthy People 2010.
     AR-12 Lobbying Restrictions.
     AR-14 Accounting System Requirements.
     AR-15 Proof of Non-Profit Status.
     AR-16 Security Clearance Requirement.
     AR-20 Conference Support.
     AR-24 Health Insurance Portability and Accountability Act 
Requirements.
     AR-25 Release and Sharing of Data.
    Additional information on these requirements can be found on the 
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm.

VI.3. Reporting Requirements

    You must provide CDC with an original, plus two hard copies of the 
following reports:
    1. Interim progress report, no less than 90 days before the end of 
the budget period. The progress report will serve as your non-competing 
continuation application, and must contain the following elements:
    a. Current Budget Period Activities Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activity Objectives.
    d. Budget.
    e. Additional Requested Information.
    f. Measures of Effectiveness.
    2. Financial status report and annual progress report, no more than 
90 days after the end of the budget period.
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    These reports must be mailed to the Grants Management or Contract 
Specialist listed in the ``Agency Contacts'' section of this 
announcement.

VII. Agency Contacts

    For general questions about this announcement, contact: Technical 
Information Management Section, CDC Procurement and Grants Office, 2920 
Brandywine Road, Atlanta, GA 30341. Telephone: 770-488-2700.
    For program technical assistance, contact: Raul A. Romaguera, DMD, 
MPH, Associate Director for Prevention in Care, Division of HIV/AIDS 
Prevention, CDC, 1600 Clifton Road, NE.--MS D-21, Atlanta, GA 30333. 
Telephone: 404-639-2004, fax: 404-639-0897, e-mail: [email protected].
    For financial, grants management, or budget assistance, contact: 
Kang Lee, Grants Management Specialist, CDC Procurement and Grants 
Office, 2920 Brandywine Road, Atlanta, GA 30341. Telephone: 770-488-
2733, e-mail: [email protected].

VIII. Other Information

    Additional information regarding Advancing HIV Prevention: New 
Strategies for a Changing Epidemic is available at the following 
Internet address Web site: http://www.cdc.gov/nchstp/od/nchstp.html.

    Dated: May 27, 2004.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-12569 Filed 6-2-04; 8:45 am]
BILLING CODE 4163-18-P